非典型或间变性组织学复发性脑膜瘤的治疗反应预测因素与生存结局
该队列研究纳入1985年1月至2014年7月在一家三级癌症中心治疗的60例首次复发时呈非典型或间变性组织学的脑膜瘤患者,中位随访36.7个月,发现首次复发时放疗作为主要或辅助治疗较单纯手术降低进展或后续复发风险(P=0.07),而首次复发时切除程度对后续复发时间无影响。
要点
- 首次复发时放疗(主要或辅助)较单纯手术降低进展或后续复发风险,P=0.07。
- 首次复发时切除程度对至后续复发时间无影响。
- 中位随访36.7个月时32例(53%)患者存活。
核心结论
- 非典型或间变性组织学复发性脑膜瘤的治疗仍具挑战性;来自最大队列之一的数据提示加用放疗可获得更好的肿瘤控制,并对首次复发时切除程度的重要性提出挑战;需要多中心努力来证实这些发现并提出治疗指南。
研究设计与样本
- 队列研究,使用1985年1月至2014年7月在一家三级癌症中心治疗的所有首次复发时呈非典型或间变性组织学脑膜瘤患者的临床数据。
- 筛查918例脑膜瘤患者,其中60例(55%女性)为首次复发时呈非典型或间变性组织学的复发病例,诊断时中位年龄58.1岁。
- 采用竞争风险回归模型分析第二次复发的预测因素。
主要发现
- 自首次复发起中位随访36.7个月,末次随访时32例(53%)患者存活。
- 首次复发时切除程度对至后续复发时间无影响。
- 首次复发时纳入放疗作为主要或辅助治疗较单纯手术降低进展或后续复发风险(P=0.07)。
关键数值与推荐
- 非典型和间变性脑膜瘤全切除后复发率在9%至50%之间,次全切除后在36%至83%之间。
局限性
- 需要多中心努力来证实这些发现并提出治疗指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recurrence rates for atypical and anaplastic meningiomas range between 9% and 50% after gross total resection and between 36% and 83% after subtotal resection. Optimal treatment of recurrent meningiomas exhibiting atypical/anaplastic histology is complicated because they are often refractory to both surgery and radiation. OBJECTIVE: To evaluate clinical determinants of recurrence and treatment-specific outcomes in patients with recurrent meningiomas exhibiting atypical/anaplastic histology at our institution. METHODS: A cohort study was conducted using clinical data of all patients treated for meningiomas with atypical/anaplastic histology at first recurrence between January 1985 and July 2014 at a tertiary cancer center. Predictors of second recurrence were analyzed using competing risks regression models. RESULTS: Nine hundred eighteen patients with meningioma were screened, of whom 60 (55% female) had recurrent disease with atypical/anaplastic histology at a median age of 58.1 yr at diagnosis. The median follow-up from the time of first recurrence was 36.7 mo, with 32 (53%) patients alive at last follow-up. There was no effect of extent of resection at first recurrence on time to a subsequent recurrence. Inclusion of radiation as primary or adjuvant therapy at first recurrence reduced the risk of progression or subsequent recurrence compared to surgery alone (P = .07). CONCLUSION: Treatment of recurrent meningiomas with atypical/anaplastic histology remains challenging. Our data, from one of the largest cohorts, suggest better tumor control with the addition of radiation and challenges the importance of extent of resection at first recurrence. A multicenter effort is needed to confirm these findings and propose treatment guidelines.
引用
- Chohan MO, Ryan CT, Singh R, et al. Predictors of Treatment Response and Survival Outcomes in Meningioma Recurrence with Atypical or Anaplastic Histology. Neurosurgery. 2018. PMID: 28645194. doi:10.1093/neuros/nyx312
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。